Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gynecologic 1Genitourinary 1

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 27Leukemia, Myeloid, Chronic-Phase 9Breast Neoplasms 6Leukemia 5Philadelphia Chromosome 4Blast Crisis 4Neoplasms 3Bronchiolitis Obliterans Syndrome 3Neoplasm Metastasis 2Leukemia, Myeloid, Accelerated Phase 2Leukemia, Myeloid 2Uterine Cervical Neoplasms 1Urinary Bladder Neoplasms 1Translocation, Genetic 1Thymus Neoplasms 1Thymoma 1Pathologic Processes 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Neoplasms by Histologic Type 1Myeloproliferative Disorders 1Multiple Myeloma 1Mesothelioma 1Lymphoma, Non-Hodgkin 1Leukemia, Myeloid, Acute 1Hematologic Diseases 1Glioblastoma 1Carcinoma, Non-Small-Cell Lung 1Bone Marrow Diseases 1Advanced Breast Cancer (Parts 1 and 2) 1

Interventions

pembrolizumab 3Drug Therapy 3Quality of Life 2Proton Therapy 2Immunotherapy 2Blood Specimen Collection 2ribociclib 1palbociclib 1napabucasin 1fludarabine 1epacadostat 1bosutinib 1amrubicin 1alovudine 1Tumor Burden 1Sunitinib 1Radiotherapy 1Radiosurgery 1Radiation 1Plicamycin 1Pemetrexed 1Patient Reported Outcome Measures 1Paclitaxel 1Nivolumab 1Molecular Diagnostic Techniques 1Magnetic Resonance Spectroscopy 1Histocompatibility Testing 1Fluorodeoxyglucose F18 1FAPI-46 1Everolimus 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Thymus Neoplasms × bosutinib × Clear all
NCT03023319 2022-06-14

Bosutinib in Combination With Pemetrexed in Patients With Selected Metastatic Solid Tumors

Augusta University

Phase 1 Completed
6 enrolled
GenitourinaryGynecologicOther solid neoplasmThoracic

Urinary Bladder Neoplasms, Carcinoma, Non-Small-Cell Lung, Uterine Cervical Neoplasms, Mesothelioma, Ovarian Neoplasms, Thymoma, Thymus Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡